Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia
Open Access
- 1 August 2021
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 196 (1) , E1-E3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Neutralizing Antibody Therapeutics for COVID-19Viruses, 2021
- Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic reviewPediatric Blood & Cancer, 2021
- Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsCancer Cell, 2021
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsBlood, 2020
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with CancerCell, 2020
- Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donorsAntiviral Research, 2020